Grief in NARS

  • Research type

    Research Study

  • Full title

    Perspectives on Dying with Non-Invasive Advanced Respiratory Support and Its Impact on Grieving – a qualitative exploration

  • IRAS ID

    346191

  • Contact name

    Jennifer Creese

  • Contact email

    jlc60@leicester.ac.uk

  • Sponsor organisation

    University of Leicester

  • Duration of Study in the UK

    1 years, 6 months, 1 days

  • Research summary

    This study, "Perspectives on Dying with Non-Invasive Advanced Respiratory Support (NARS) and Its Impact on Grieving – a qualitative exploration," aims to understand how the use of NARS in end-of-life care affects the grieving process of bereaved loved ones. NARS, such as continuous positive airway pressure (CPAP) and non-invasive ventilation (NIV), is commonly used for treating respiratory failure in patients with conditions like chronic obstructive pulmonary disease (COPD), heart failure, and obesity hypoventilation syndrome. While NARS can prolong life, patients who require it are critically ill, and mortality rates are high. For example, the mortality rate for older adults with COVID-19 using CPAP can be as high as 85% and NIV for COPD carries a 12% mortality rate. The process of dying while using NARS is complex and can be distressing for both patients and their families, with significant symptom burden and challenges in providing care.
    The study, led by Dr. Jennifer Creese and Dr. David S. Wenzel, will involve interviewing 10-30 bereaved loved ones who have experienced the death of a loved-one who used NARS. These interviews, which can take place in person, over the phone, or via video call, will explore their perspectives on the care provided, communication about prognosis and treatment decisions, and the overall impact on their grieving process. By using interpretive phenomenological analysis (IPA), the researchers aim to deeply understand how these loved ones make sense of their experiences and identify ways to improve support during and after the end-of-life care process.
    The study will be conducted over one year, and all data will be anonymized and securely stored. The findings will be published in academic journals and presented at conferences to inform better practices in end-of-life care. This research is crucial for developing interventions that can alleviate the emotional burden on families and enhance the quality of care provided to patients in their final days.

  • REC name

    Wales REC 7

  • REC reference

    24/WA/0284

  • Date of REC Opinion

    30 Sep 2024

  • REC opinion

    Favourable Opinion